Aviv Gazit

USPTO Granted Patents = 30 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.3

ph-index = 15

Forward Citations = 942(Granted Patents)

Company Filing History:

15 out of 891

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Max-planck-gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

4. 4 out of 343

Ben-gurion University of the Negev Research and Development Authority

patents

5. 2 out of 4

Yissum Research Development

patents

6. 2 out of 111

Rhone-poulenc Rorer Pharmaceuticals Inc.

patents

7. 1 out of 5

Bio-signal Corporation Ltd.

patents

8. 1 out of 169

Hadasit Medical Research Services and Development Ltd.

patents

9. 1 out of 15,458

University of California

11. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2017

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9670139 - Telomerase activating compounds and methods of use thereof (2017-06-06),

2. 9663448 - Tri-aryl compounds and compositions comprising the same (2017-05-30),

3. 8609736 - Telomerase activating compounds and methods of use thereof (2013-12-17),

4. 8604245 - Tri-aryl compounds and compositions comprising the same (2013-12-10),

5. 7964399 - Cell line comprising vector encoding truncated FLK-1 receptor (2011-06-21),

6. 7217737 - Method and compositions for inhibiting cell proliferative disorders (2007-05-15),

7. RE38761 - Styryl compounds which inhibit EGF receptor protein tyrosine kinase (2005-07-18),

8. 6872699 - Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein (2005-03-29),

9. 6673798 - PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same (2004-01-06),

10. 6596878 - Methods and compositions for inhibiting cell proliferative disorders (2003-07-22),

11. 6426366 - Pharmaceutical compositions comprising tyrphostins (2002-07-30),

12. 6358954 - PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same (2002-03-19),

13. 6331555 - Treatment of platelet derived growth factor related disorders such as cancers (2001-12-18),

14. 6126917 - Epidermal growth factor receptor binding compounds for positron emission (2000-10-03),

15. 5990141 - Treatment of platelet derived growth factor related disorders such as (1999-11-23),

Title: The Innovative Mind of Aviv Gazit

Introduction: Aviv Gazit, a visionary inventor hailing from Jerusalem, Israel, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Aviv Gazit holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing his commitment to creating sustainable solutions for the future.

Career Highlights: With a career spanning over two decades, Aviv Gazit has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Aviv Gazit has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge-sharing that has led to remarkable advancements in various fields.

Conclusion: Aviv Gazit's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, solidifies his status as a true pioneer in the world of technology and invention.

This text is generated by artificial intelligence and may not be accurate.